Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-075462

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 11, 2016P4,153$17.9337A2,568,706ISee Footnote
Common StockF1Jan 12, 2016P5,941$19.1188A2,574,647ISee Footnote
Common StockF2,F1Jan 13, 2016P5,543$19.9665A2,580,190ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses